ICU Medical Inc.

210.08-1.62-0.77%Vol 18.00K1Y Perf -6.29%
Apr 19th, 2021 12:21 DELAYED
BID209.84 ASK210.42
Open211.98 Previous Close211.70
Pre-Market- After-Market-
 - -%  - -
Target Price
240.50 
Analyst Rating
Strong Buy 1.33
Potential %
14.55 
Finscreener Ranking
★★★★     53.95
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★     55.63
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★+     64.47
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap4.45B 
Earnings Rating
Neutral
Price Range Ratio 52W %
59.92 
Earnings Date
6th May 2021

Today's Price Range

209.01211.98

52W Range

170.57236.51

5 Year PE Ratio Range

31.30193.80

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
3.68%
1 Month
3.05%
3 Months
-1.75%
6 Months
6.29%
1 Year
-6.29%
3 Years
-17.42%
5 Years
100.49%
10 Years
374.03%

TickerPriceChg.Chg.%
ICUI210.08-1.6200-0.77
AAPL134.260.10000.07
GOOG2 296.75-1.0100-0.04
MSFT258.70-2.0400-0.78
XOM56.21-0.4500-0.79
WFC43.890.05000.11
JNJ162.700.46000.28
FB302.26-3.9200-1.28
GE13.34-0.0500-0.37
JPM153.00-0.3000-0.20
Earnings HistoryEstimateReportedSurprise %
Q04 20201.291.5217.83
Q03 20201.101.6146.36
Q02 20201.021.4542.16
Q01 20201.381.5613.04
Q04 20191.481.7316.89
Q03 20191.511.520.66
Q02 20191.861.77-4.84
Q01 20191.962.3519.90
Earnings Per EndEstimateRevision %Trend
3/2021 QR1.32-2.94Negative
6/2021 QR1.40-4.11Negative
12/2021 FY6.04-0.98Negative
12/2022 FY6.89-1.29Negative
Next Report Date6th May 2021
Estimated EPS Next Report1.32
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume18.00K
Shares Outstanding21.19M
Trades Count888
Dollar Volume16.88M
Avg. Volume120.48K
Avg. Weekly Volume77.31K
Avg. Monthly Volume105.60K
Avg. Quarterly Volume109.98K

ICU Medical Inc. (NASDAQ: ICUI) stock closed at 211.7 per share at the end of the most recent trading day (a 1.65% change compared to the prior day closing price) with a volume of 124.26K shares and market capitalization of 4.45B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 8000 people. ICU Medical Inc. CEO is Vivek Jain.

The one-year performance of ICU Medical Inc. stock is -6.29%, while year-to-date (YTD) performance is -1.3%. ICUI stock has a five-year performance of 100.49%. Its 52-week range is between 170.57 and 236.51, which gives ICUI stock a 52-week price range ratio of 59.92%

ICU Medical Inc. currently has a PE ratio of 50.70, a price-to-book (PB) ratio of 2.88, a price-to-sale (PS) ratio of 4.62, a price to cashflow ratio of 19.80, a PEG ratio of 2.32, a ROA of 4.82%, a ROC of 5.76% and a ROE of 5.79%. The company’s profit margin is 7.52%, its EBITDA margin is 15.30%, and its revenue ttm is $942.40 Million , which makes it $44.47 revenue per share.

Of the last four earnings reports from ICU Medical Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.32 for the next earnings report. ICU Medical Inc.’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for ICU Medical Inc. is Strong Buy (1.33), with a target price of $240.5, which is +14.55% compared to the current price. The earnings rating for ICU Medical Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ICU Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ICU Medical Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 13.83, ATR14 : 6.57, CCI20 : 204.79, Chaikin Money Flow : 0.02, MACD : -1.71, Money Flow Index : 55.26, ROC : 1.91, RSI : 47.96, STOCH (14,3) : 83.62, STOCH RSI : 1.00, UO : 50.06, Williams %R : -16.38), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ICU Medical Inc. in the last 12-months were: Brian Bonnell (Sold 0 shares of value $0 ), Christian Voigtlander (Option Excercise at a value of $0), Daniel Woolson (Option Excercise at a value of $0), David C. Greenberg (Sold 0 shares of value $0 ), David F. Hoffmeister (Sold 0 shares of value $0 ), Donald Abbey (Sold 0 shares of value $0 ), Elisha W. Finney (Sold 0 shares of value $0 ), Elisha W. Finney (Sold 1 580 shares of value $300 200 ), George A. Lopez (Option Excercise at a value of $3 703 665), George A. Lopez (Sold 130 000 shares of value $25 950 660 ), Kevin J. McGrody (Sold 0 shares of value $0 ), Robert S. Swinney (Option Excercise at a value of $233 130), Robert S. Swinney (Sold 877 shares of value $169 091 ), Virginia Ruth Sanzone (Option Excercise at a value of $0), Vivek Jain (Option Excercise at a value of $7 436 935), Vivek Jain (Sold 141 500 shares of value $29 675 049 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
0 (0.00 %)
Moderate Buy
1 (33.33 %)
1 (33.33 %)
1 (50.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
1 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.33
Strong Buy
1.33
Moderate Buy
2.50

ICU Medical Inc.

ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU's acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding either the largest or second largest market share position in all its reporting segments: Infusion consumables (#1 market share, 40% of companywide revenue), IV solutions (#2 market share behind Baxter, 24% of companywide revenue), Infusion systems (#2 market share behind Becton Dickson, 32% of companywide revenue), and Critical care (4% of companywide revenue). The combined entity remains primarily U.S. focused, generating roughly 75% of its sales domestically.

CEO: Vivek Jain

Telephone: +1 949 366-2183

Address: 951 Calle Amanecer, San Clemente 92673, CA, US

Number of employees: 8 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

53%47%

Bearish Bullish

51%49%

News

Stocktwits